While billions are being invested in new drug development and cutting-edge biotech facilities, a quieter challenge often goes unnoticed: the way daily drug manufacturing operations are coordinated. Even in the most advanced facilities, the complexity of aligning people, equipment and processes is still being managed through a patchwork of spreadsheets and manual decisions. This isn't a sign of poor management, it's the reality of heavily regulated industries built on legacy systems.

As a result, valuable capacity can remain hidden, and production delays can ripple through the supply chain, sometimes contributing to shortages. Many teams acknowledge scheduling as a persistent challenge, often saying it's "too complex or costly to fix". Traditional solutions have always been heavy, expensive and slow to deliver value, which is eactly why it was worth rethinking.